I was lucky enough to attend this year's Ginkgo Ferment Summit at the end of October 2021. Because of the pandemic, this was the first time in two years that Ginkgo Bioworks held the event. Here are a few learnings.

Once you’ve engineered your microorganism to produce your billion-dollar molecule, how are you going to scale up production?

In 2020, A16Z’s Vijay Pande and Judy Savitskay wrote a paper called, The Biggest Open Opportunity in Synthetic Biology, listing out the need for novel bio-manufacturing platforms.